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Abstract Elucidation of the mechanism of formation of
insoluble protein aggregates is essential to resolve problems such
as protein folding diseases. In this study the effects of various
types of biomolecules on the aggregation of denatured proteins
were investigated. Denatured K-lactalbumin, an acidic protein,
was found to be precipitated by lactoferricin, a basic peptide
derived from lactoferrin. Denatured lysozyme, a basic protein, by
itself showed aggregation, which was promoted by addition of
native K-lactalbumin. Heparin and nucleic acids caused almost
instant aggregation of denatured lysozyme. Native lactoferricin
was also found to aggregate with heparin or nucleic acids. The
results show that denatured/misfolded proteins as well as peptides
are highly reactive with other cellular components to form
insoluble aggregates and suggest a possible mechanism by which
protein folding diseases progress. Most of the above aggregation
reactions were inhibited by lactoferrin, which could form soluble
complexes with denatured K-lactalbumin, heparin, and nucleic
acids.
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1. Introduction
Protein folding is an important issue both in the production
of recombinant proteins in bacteria such as Escherichia coli [1]
and in tackling protein folding diseases such as prion and
Alzheimer’s diseases [2]. In the former case one often encoun-
ters inclusion bodies, which must be solubilized by denatur-
ants and then refolded into their native conformation e⁄-
ciently. In the latter misfolded proteins are thought to be
causative agents of the diseases. Both cases involve aggrega-
tion of proteins leading to accumulation of insoluble deposits.
Thus, elucidation of the mechanism of formation of insoluble
protein aggregates is essential to resolve these problems. Most
previous studies on protein folding and aggregation have dealt
with the self-association of pure proteins without interacting
ligands except molecular chaperones. In the course of screen-
ing ligands that might promote protein folding, I have found
that some natural substances have adverse e¡ects, causing
precipitation of denatured proteins and thus preventing the
proper folding. Since signi¢cant precipitation was observed
at a physiological ionic strength and at low ligand concentra-
tions, it is postulated that this kind of aggregation reaction
may be signi¢cant in vivo if unfolded proteins exist. A possi-
ble link of this ¢nding with protein folding diseases is dis-
cussed.
Lactoferrin is an iron-binding glycoprotein present in milk
and other secretions [3]. It is thought to be involved in host
defense by acting as an antimicrobial agent or by stimulating
the immune system. The bactericidal domain is located at the
N-terminal portion, which can be released by pepsin digestion
of the 80-kDa protein [4]. The bactericidal peptide is named
lactoferricin and is rich in arginine and lysine; HLFcin cor-
responds to the N-terminal residues 1^47 having two intra-
molecular disul¢de bonds, BLFcin to residues 17^41 having
one intramolecular disul¢de bond [5]. I have tested these cog-
nate peptides and proteins for interactions with denatured
proteins and found mutually opposing e¡ects. Lactoferrin
was found to protect denatured proteins from aggregation
induced with lactoferricin and other ligands. The result is
discussed in relation to the diseases caused by peptides derived
from precursor proteins.
2. Materials and methods
2.1. Materials
Bovine K-lactalbumin, CM-K-lactalbumin, human lactoferrin, bo-
vine lactoferrin, ribonuclease A, bovine serum albumin, low molecular
weight heparin from porcine intestinal mucosa (sodium salt; average
molecular weight V3000) (heparin fragment), poly[C], and poly-
[C]Wpoly[G] were purchased from Sigma. Hen egg-white lysozyme
(6U crystallized) was from Seikagaku. R-lysozyme and heparin (so-
dium salt) were from Wako. Urea (biochemical grade) and dithio-
threitol (biochemical grade) were from Nacalai Tesque. tRNA from
brewer’s yeast was from Boehringer Mannheim. VDNA was from
Takara. OligoDNA was custom-synthesized. BLFcin and HLFcin
were kindly provided by Morinaga Milk Industry, Japan. All of the
above reagents were used without further puri¢cation. Nucleic acids
were dissolved in sterile water or bu¡er and stored at 380‡C until use.
Urea solution was prepared fresh each time. Either dithiothreitol was
dissolved just before use or a 0.2 M solution was stored at 320‡C for
a single use.
2.2. Refolding experiments and turbidity measurements
Unless otherwise noted, the experiments were done in 20 mM Tris-
HCl+0.15 M NaCl (pH 7.5). K-Lactalbumin and lysozyme were used
as model proteins. The two proteins are structurally homologous with
four disul¢de bonds, but have di¡erent isoelectric points: V4.5 for K-
lactalbumin and V11 for lysozyme [6].
K-Lactalbumin was denatured in 7.2 M urea+2 mM dithiothreitol
at room temperature for 30 min. Lysozyme was denatured in 8.1 M
urea+2 mM dithiothreitol at 40‡C for 2 h under nitrogen. The dena-
tured proteins were subjected to refolding by 50-fold dilution into
bu¡er with or without an additive(s). To monitor turbidity with
time, 2 Wl of the denatured protein solution was ¢rst placed in a
microcuvette and then 98 Wl of the refolding bu¡er was added and
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mixed immediately by pipetting in and out. About 2 min later, record-
ing of absorbance at 550 nm was started and this continued for 20
min. A Pharmacia Ultrospec Plus spectrophotometer with a 70-Wl
ultramicrovolume black cell was used.
2.3. Gel ¢ltration analysis
Protein-protein interactions were analyzed by gel ¢ltration using a
Superose 12 PC 3.2/30 column on the SMART system (Pharmacia).
The column was equilibrated and run with 20 mM Tris-HCl+0.15 M
NaCl (pH 7.5) at a £ow rate of 40 Wl/min at room temperature. The
column was calibrated with a gel ¢ltration calibration kit from Phar-
macia. Before each run, the sample was mixed in the same bu¡er and
¢ltered through an Ultrafree C3-GV (0.22 Wm) ¢lter (Millipore). A
volume of 40 Wl was applied. The apparent molecular weights for the
protein peaks were evaluated from the plots of Kav vs. log(molecular
weight), where Kav=(Ve3Vo)/(Vt3Vo), where Ve is the elution vol-
ume, Vo the void volume, and Vt the total bed volume [7]. The mo-
lecular weights of lactoferrin and K-lactalbumin thus obtained were
not quite compatible with the known values, ca. 80 000 [3] and 14 200
[6] for the two proteins, respectively. The reasons for the discrepancy
were not pursued in this study.
3. Results
3.1. Aggregation of denatured proteins
Denatured and reduced K-lactalbumin did not show any
signi¢cant aggregation leading to precipitation when refolded
at 90 Wg/ml in 20 mM Tris-HCl+0.15 M NaCl (pH 7.5) with-
out any additives, although the reduced protein was expected
to assume a denatured or misfolded conformation under the
non-denaturing condition (the ¢nal concentrations of urea
and dithiothreitol were 0.14 M and 40 WM, respectively) [8].
Addition of 20 Wg/ml or more of BLFcin to this refolded
solution caused a time-dependent precipitation. The same re-
sult was obtained when the refolding was conducted in the
presence of BLFcin (Fig. 1A). HLFcin was found to have a
similar e¡ect. Refolded lysozyme (90 Wg/ml) by itself showed
aggregation, which was promoted by the addition of native K-
lactalbumin (Fig. 1A). Addition of 10 Wg/ml or more of hep-
arin or heparin fragment caused rapid aggregation, the latter
being more e¡ective (Fig. 1A). These aggregation reactions
could be observed at protein concentrations as low as 10^20
Wg/ml (exception: without an additive, denatured lysozyme
did not precipitate at 20 Wg/ml). R-lysozyme [9], which did
not by itself have a tendency to aggregate, was also aggre-
gated with heparin or heparin fragment in a similar manner
(data not shown). Various kinds of nucleic acids, double-
stranded or single-stranded DNA, RNA, and oligonucleotide,
had similar e¡ects to those of heparin and heparin fragment
on denatured lysozyme (Fig. 1B); similarly, tRNA and a sin-
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Fig. 1. Time course of aggregation. The e¡ects of various additives
on 90 Wg/ml denatured K-lactalbumin (A, ¢lled circles), 90 Wg/ml de-
natured lysozyme (A, open symbols; B), and 100 Wg/ml BLFcin (C)
in 20 mM Tris-HCl+0.15 M NaCl (pH 7.5). Although the absorb-
ance at 550 nm was recorded continuously, each curve is plotted
with a speci¢c symbol at certain time intervals to distinguish them
from each other. The dashed lines indicate that the additives con-
tained HLF. The additives (the numbers denote concentrations in
mg/ml) are: in A, 9b9, BLFcin 0.04; 9a9, none; 9E9, K-lactal-
bumin 0.05; 9O9, heparin 0.1; 979, heparin fragment 0.1; - -
b- -, BLFcin 0.04+HLF 1.0; -O-, heparin 0.1+HLF 2.0; - -7- -,
heparin fragment 0.1+HLF 1.0. In B, 9a9, none; 9O9, tRNA
0.01; 9E9, VDNA 0.01 (oligoDNA 0.01 and poly[C] 0.01 almost
overlap this curve); 979, poly[C]Wpoly[G] 0.01; - -O- -, tRNA
0.01+HLF 0.2; - -E- -, VDNA 0.01+HLF 1.0; plus-in-square, oli-
goDNA 0.01+HLF 1.0; black-and-white square, poly[C] 0.01+HLF
0.2; - -7- -, poly[C]Wpoly[G] 0.01+HLF 1.0. In C, 9a9, heparin
0.05; 9O9, heparin fragment 0.1; 9E9, poly[C] 0.01; 979, oli-
goDNA 0.01; 9|9, tRNA 0.01; black-and-white diamond, VDNA
0.01; 9U9, poly[C]Wpoly[G] 0.01; - -a- -, heparin 0.05+HLF 2.0; - -
O- -, heparin fragment 0.1+HLF 2.0; - -E- -, poly[C] 0.01+HLF 0.2;
- -7- -, oligoDNA 0.01+HLF 1.0.
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gle-stranded poly[C] had prominent e¡ects on R-lysozyme,
but the e¡ects of double-stranded VDNA and poly[C]Wpoly[G]
were small, though signi¢cant (data not shown). Urea-dena-
tured K-lactalbumin and lysozyme without dithiothreitol
treatment, as well as the native proteins, did not show any
aggregation behaviors under the same conditions as above
(native lysozyme at 0.4 and 1.5 mg/ml or greater formed pre-
cipitates with 0.1 mg/ml heparin and heparin fragment, re-
spectively). All of the above aggregations, except for the
self-aggregation of lysozyme and the e¡ect of K-lactalbumin,
could be prevented e¡ectively by the presence of lactoferrin;
usually, 1 mg/ml lactoferrin was required for the e¡ect, but 0.2
mg/ml was e¡ective against tRNA and poly[C] (Fig. 1A,B).
Both human and bovine lactoferrin were e¡ective. Ribonu-
clease A, bovine serum albumin, and lysozyme did not have
such protective e¡ects as lactoferrin.
3.2. Reaction of BLFcin with heparin and nucleic acids
Native BLFcin, as well as denatured and reduced BLFcin,
was found to react with heparin and nucleic acids, leading to
precipitation (Fig. 1C). As was the case with denatured lyso-
zyme, the aggregation was signi¢cant at 10 Wg/ml heparin
(fragment) or nucleic acids (BLFcin 0.1 mg/ml). Heparin frag-
ment was more e¡ective than heparin. The e¡ects of tRNA,
poly[C], and oligoDNA were quite prominent, while those of
VDNA and poly[C]Wpoly[G] were small. Lactoferrin was e¡ec-
tive in preventing these aggregation reactions (Fig. 1C).
3.3. Complex formation between denatured protein and
lactoferrin
The interactions of lactoferrin with native and denatured K-
lactalbumin were studied by gel ¢ltration (Fig. 2). As a model
of the denatured protein, CM-K-lactalbumin was used because
it did not require a reducing bu¡er condition to avoid possible
precipitation arising from intermolecular disul¢de bond for-
mation. CM-K-lactalbumin did form a precipitate in the pres-
ence of BLFcin, though at much higher concentrations of
BLFcin (v 0.2 mg/ml) than for urea-denatured reduced K-lac-
talbumin (data not shown). The precipitation could be e¡ec-
tively prevented by inclusion of 0.5^1.0 mg/ml human lacto-
ferrin. Thus, it is assumed that lactoferrin interacts with CM-
K-lactalbumin in a similar manner to that with the urea-dena-
tured reduced protein.
The CM-K-lactalbumin sample used in the present study
had a broad molecular weight distribution (Fig. 2) possibly
due to oligomerization of protein species with di¡erent de-
grees of modi¢cation (the manufacturer indicates at least
6 mol of S-carboxymethylcysteine per mol protein). Never-
theless, a shift of the peak position of lactoferrin to a higher
molecular weight is evident when lactoferrin was mixed with
CM-K-lactalbumin, the increase being about 6000 in molecu-
lar weight. Analysis by superposition of the curves suggested
that it was the higher molecular weight species of CM-K-lact-
albumin that reacted with lactoferrin (data not shown). On
the other hand, native K-lactalbumin shifted the peak position
of lactoferrin only slightly, the increase in molecular weight
being about 2000. Essentially the same results were obtained
at di¡erent mixing ratios of lactoferrin and CM- or native
K-lactalbumin (molar ratios of 1:4 (Fig. 2); 1:2; 1:1), which
demonstrates the formation of a complex between lactoferrin
and CM-K-lactalbumin, a denatured protein.
4. Discussion
In the present study the interactions of denatured proteins
with various types of biomolecules were investigated under
non-denaturing conditions. It was found that at a physiolog-
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Fig. 3. Interactions involving misfolded proteins. The unfavorable
(aggregate-forming; closed two-headed arrows) and favorable (pro-
tective; open two-headed arrows) interactions proposed on the basis
of the present results are shown. The disease-causing unwanted spe-
cies are tinted. Closed one-headed: degradation. The dashed line in-
dicates that the interaction is merely suspected. The category ‘neuro-
peptides’ represents any biologically active peptides. The
aggregation caused by a peptide fragment could be prevented by its
parent protein, as in the case of lactoferricin and lactoferrin. This
might also hold for amyloid L-peptide and amyloid precursor pro-
tein or its secreted form containing a C-terminal heparin-binding
domain [20].
Fig. 2. Gel ¢ltration of human lactoferrin (0.7 mg/ml) in the pres-
ence and absence of CM-K-lactalbumin (0.5 mg/ml) or native K-lac-
talbumin (0.5 mg/ml) in 20 mM Tris-HCl+0.15 M NaCl (pH 7.5).
solid line, lactoferrin; dashed line, CM-K-lactalbumin; dot-dashed
line, K-lactalbumin; circle line, lactoferrin+CM-K-lactalbumin;
hatched line, lactoferrin+K-lactalbumin. The elution positions of the
following standard proteins are indicated by arrows with molecular
weights in kDa: aldolase (158.0 kDa), bovine serum albumin (67.0
kDa), ovalbumin (43.0 kDa), chymotrypsinogen A (25.0 kDa), and
ribonuclease A (13.7 kDa).
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ical ionic strength denatured/misfolded proteins tend to form
insoluble aggregates by combining with other cellular compo-
nents: native peptides, proteins, glycosaminoglycans (GAGs)
such as heparin, and nucleic acids. The aggregating interac-
tions required reduction of disul¢de bonds and oppositely
charged molecules, suggesting that they involve electrostatic
interactions between a protein in an extended conformation
and a ligand. Thus, the denatured state of an acidic protein K-
lactalbumin reacted with a basic peptide BLFcin but not with
negatively charged heparin or nucleic acids; conversely, the
denatured state of a basic protein lysozyme reacted with hep-
arin and nucleic acids but not with BLFcin. On the other
hand, the disul¢de-bonded small peptide, BLFcin, formed
precipitates with heparin and nucleic acids. Most of these
aggregation reactions were found to be prevented by lactofer-
rin, which could form soluble complexes with denatured K-
lactalbumin (Fig. 2), heparin [10], and nucleic acids [11]. Lac-
toferrin has an isoelectric point of V8.7 [12] and the protec-
tive e¡ect of lactoferrin may be ascribed to the localized
charge distribution throughout the molecule [13]; thus, lacto-
ferricin, which was derived from the N-terminal basic region
that constitutes the GAG-binding site [10], causes the aggre-
gation of denatured K-lactalbumin, whereas the parent lacto-
ferrin molecule a¡ords protection. These e¡ects were found to
be highly sensitive to the ionic strength: in the absence of
NaCl, substantial e¡ects were observed at 20 Wg/ml BLFcin
and at 20^100 Wg/ml lactoferrin (data not shown), again sug-
gesting the importance of electrostatic interactions.
The proposed interactions involving misfolded proteins
based on the present results are summarized in Fig. 3. If, by
any mechanism, a misfolded protein happens to be formed, it
may be deleterious for the cell since it could inactivate certain
biologically active peptides such as neuropeptides and en-
zymes or inhibit protein synthesis by reacting with nucleic
acids or nascent polypeptides. Peptide fragments produced
by protein degradation may also react with the misfolded
protein. These reactions produce aggregates that could act
as a seed for triggering extensive aggregation, which eventu-
ally leads to the deposition of insoluble aggregates. Then, one
of the consequences to occur in the cell would be to produce
free radicals by a defense mechanism, which, at the same time,
may damage the normal structural components such as
GAGs; actually, amyloid L-peptide is reported to damage
cells by producing free radicals [14,15]. The GAG fragments
thus released might in turn complex with the misfolded pro-
tein, peptides, or even nascent polypeptides. The rapid asso-
ciation of heparin fragment with misfolded lysozyme observed
in this study is noteworthy in this respect. Two human lyso-
zyme variants are known to be amyloidogenic [16] and the
amyloid deposits also contain GAGs [17]. It should also be
noted that GAGs were found to be associated with amyloid
plaques and neuro¢brillary tangles in Alzheimer’s disease
[18,19]. The consumption of proteins and peptides as above
might stimulate further protein synthesis, resulting in overex-
pression and misfolding. Thus, the present study suggests a
new mechanism by which some kinds of protein folding dis-
eases progress; it proposes how protein aggregation is pro-
voked and how it leads to neuronal disorders and cellular
dysfunction. Lactoferrin protects some misfolded proteins
from aggregating by this mechanism. The same mechanism
may also be worth consideration in understanding the inclu-
sion body formation.
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